Medicare Enrolled
Dr. Richard Gordon, D.O.
Optician · Voorhees, NJ
Practice pattern: Mixed Practice
— Diverse clinical practice across multiple procedure types
Low-engagement
Very High
DATA COVERAGE
Data in 4 of 4 federal sources
Measures public federal data availability — not provider quality
Informational, not a quality rating.
This page presents federal public records about Dr. Gordon from CMS (NPPES, Open Payments, Medicare Provider Utilization, PECOS). It is not medical advice, an endorsement, or a judgment of clinical quality. Always consult the provider directly and a licensed clinician for medical decisions. Read methodology →
Are you Dr. Gordon?
Request a correction or review of any data shown here. Provider portal →
What this data tells you about Dr. Gordon
Dr. Richard Gordon is an optician specialist in Voorhees, NJ, with 21 years of NPI registration. Based on federal Medicare data, Dr. Gordon performed 158,469 Medicare services across 2,077 unique beneficiaries.
Between the years covered by Open Payments, Dr. Gordon received a total of $40,199 from 105 pharmaceutical and/or device companies across 1785 individual payments. These payments are legal, publicly disclosed under the federal Sunshine Act, and common in optician. Most payments are for meals and travel — low-value interactions common across virtually all practicing physicians. Patients may wish to discuss these relationships with their provider.
The Data Coverage level for Dr. Gordon is Very High — reflecting how much public federal data is available about this provider. Patients are encouraged to use this data as one of several factors when choosing a healthcare provider.
✓ 21 years in practice
▲ Top 0% volume in NJ
$40,199 industry payments
Medicare Practice Summary
Medicare Utilization ↗158,469
Medicare services
Top 0% in NJ for optician
2,077
Unique beneficiaries
$2
Avg. Medicare payment
Medicare patients only (65+ / disabled) · How to read this →
~7,546 Medicare services per year of practice
Top procedures by volume
Ranked by number of services performed for Medicare patients. Avg. submitted charge is what the provider billed; avg. Medicare payment is what CMS paid.
| Procedure | Volume | Avg. paid | Avg. submitted |
|---|---|---|---|
| Iron infusion (Injectafer) An intravenous injection of ferric carboxymaltose, an iron replacement medication. |
150,000 | $1 | $2 |
| Dexamethasone injection (steroid) An injection of dexamethasone sodium phosphate, a corticosteroid medication, administered in a dose of 1 milligram. |
2,444 | $0 | $2 |
| Complete blood count (CBC) with differential An automated laboratory test that measures the levels of red blood cells, white blood cells, and platelets in the blood, including a breakdown of the different types of white blood cells. |
1,165 | $8 | $43 |
| Office visit, established patient (20-29 min) An office visit for an existing patient lasting between 20 and 29 minutes. The visit involves medical evaluation and management of the patient's condition. |
1,125 | $70 | $292 |
| Blood draw (venipuncture) Insertion of a needle into a vein to collect a blood sample. |
844 | $8 | $36 |
| Injection, granisetron hydrochloride, 100 mcg | 410 | $0 | $21 |
| Intravenous injection of additional new drug or substance Administration of an additional new medication or substance directly into a vein. |
345 | $13 | $203 |
| Office visit, established patient (30-39 min) A follow-up office visit for an existing patient lasting between 30 and 39 minutes. The visit involves medical evaluation and management of the patient's condition. |
344 | $101 | $460 |
| Intravenous infusion, 1 hour or less Administration of medication or fluid directly into a vein for therapeutic, preventive, or diagnostic purposes. The procedure lasts one hour or less. |
288 | $56 | $202 |
| Intravenous chemotherapy infusion, 1 hour or less Administration of chemotherapy medication directly into a vein. The procedure takes one hour or less to complete. |
202 | $113 | $406 |
| Drug injection, under skin or into muscle A procedure involving the administration of a medication or substance via injection into the subcutaneous tissue or muscle. |
190 | $12 | $60 |
| Additional hour of intravenous infusion This code represents each additional hour of intravenous infusion beyond the initial hour for therapy, prevention, or diagnosis. |
144 | $18 | $178 |
| Diphenhydramine injection, up to 50 mg An injection of diphenhydramine hydrochloride, an antihistamine medication, administered in a dose of up to 50 milligrams. |
116 | $1 | $10 |
| Additional sequential IV infusion, 1 hour or less This code represents an additional intravenous infusion administered sequentially to a primary infusion. It covers the administration time of one hour or less. |
96 | $25 | $204 |
| Basic metabolic blood panel A blood test that measures a group of basic chemicals, including total calcium levels. |
85 | $8 | $66 |
| Non-hormonal chemotherapy injection This procedure involves administering non-hormonal anti-neoplastic chemotherapy medication via injection into the skin or muscle tissue. |
83 | $63 | $182 |
| Unclassified drug A medication that does not fit into standard HCPCS or CPT classification categories. |
79 | $1 | $50 |
| Enhanced Oncology Model monthly payment This code represents the monthly enhanced oncology services payment under the Enhancing Oncology Model. It covers the administrative payment for enhanced services provided to eligible patients. |
68 | $70 | $92 |
| New patient office visit (45-59 min) An initial office visit for a new patient lasting between 45 and 59 minutes. This code covers the total time spent by the physician or qualified healthcare professional on the date of the encounter. |
63 | $133 | $387 |
| Additional hour of intravenous chemotherapy This code represents the administration of chemotherapy medication into a vein for each additional hour beyond the initial period. |
55 | $25 | $203 |
| Office visit, established patient (10-19 min) An office visit for an existing patient lasting 10 to 19 minutes. The visit involves medical evaluation and management of the patient's condition. |
53 | $45 | $202 |
| New patient office visit (30-44 min) An initial office visit for a new patient lasting between 30 and 44 minutes. This code is used when the total time spent on the date of the encounter falls within this range. |
52 | $88 | $256 |
| Intravenous infusion of new drug or substance, 1 hour or less This procedure involves administering a new medication or substance directly into a vein through an existing access site. The infusion is completed within one hour or less. |
51 | $57 | $203 |
| Concurrent intravenous infusion Administration of medication or fluid into a vein for therapy, prevention, or diagnosis while another infusion is being given. |
36 | $17 | $102 |
| Intravenous drug injection A procedure involving the administration of a medication or substance directly into a vein. |
33 | $33 | $304 |
| Automated urinalysis An automated laboratory test performed on a urine sample to analyze its chemical and physical properties. The procedure uses machinery to detect various substances and cells within the urine. |
32 | $2 | $14 |
| Irrigation of implanted venous access device This procedure involves flushing an implanted venous access device to clear blockages or maintain patency. It ensures the device remains functional for delivering medications or fluids. |
27 | $22 | $202 |
| Office visit for established patient An office visit for an existing patient that may not require the healthcare professional to be present. |
22 | $19 | $47 |
| Office visit, established patient, complex (40-54 min) An office or outpatient visit for an existing patient lasting between 40 and 54 minutes. This level of service is determined by the total time spent on the date of the encounter. |
17 | $142 | $547 |
How to read this data: This reflects Medicare patients only (typically 65+). Payment amounts are what Medicare paid the provider, not your out-of-pocket cost. A higher procedure volume generally indicates more experience with that procedure.
95.2% high complexity
2.3% medium
2.5% routine
Industry Payment Transparency
Open Payments through 2024 ↗$40,199
Total received (2018-2024)
Avg $5,743/year across 7 years
Top 5% in NJ for optician
A higher payment rank reflects disclosed industry relationships (consulting, research, speaking) common among subspecialists — not wrongdoing.
105
Companies
1,785
Individual payments
All payments are legal and publicly reported · Not evidence of wrongdoing · How to interpret →
Payment profile
Industry payments classified by relationship type. Not all payments are equal — research and consulting reflect different relationships than speaking programs or meals.
Meals & Travel
Food, beverages, travel, and lodging — typically low-value
$35,762 (89.0%)
Speaking / Promotional
Speaker programs, honoraria, and industry-sponsored educational events
$2,519 (6.3%)
Other
Charitable contributions, space rental, and other categories
$1,792 (4.5%)
Consulting
Expert advisory fees, typically reflecting recognized clinical expertise
$126 (0.3%)
Payment trend by year
Annual totals from pharmaceutical and medical device companies.
2024
$5,715
2023
$6,671
2022
$7,330
2021
$7,161
2020
$4,713
2019
$5,629
2018
$2,981
Payments by company (2024)
Consulting
Speaking
Meals & Travel
Research
Janssen Biotech, Inc.
$730
AstraZeneca Pharmaceuticals LP
$438
PFIZER INC.
$358
ABBVIE INC.
$324
Novartis Pharmaceuticals Corporation
$310
Daiichi Sankyo Inc.
$290
Incyte Corporation
$273
SOBI, INC
$207
E.R. Squibb & Sons, L.L.C.
$190
Ipsen Biopharmaceuticals, Inc
$177
Teleflex LLC
$160
Karyopharm Therapeutics Inc.
$159
Eisai Inc.
$145
Bayer Healthcare Pharmaceuticals Inc.
$144
Regeneron Healthcare Solutions, Inc.
$141
Merck Sharp & Dohme LLC
$133
Astellas Pharma US Inc
$125
Gilead Sciences, Inc.
$120
Celgene Corporation
$114
Takeda Pharmaceuticals U.S.A., Inc.
$109
Genentech USA, Inc.
$106
Lilly USA, LLC
$99
Genmab U.S., Inc.
$89
Tempus AI, Inc
$89
Stemline Therapeutics Inc.
$72
GENZYME CORPORATION
$69
SERVIER PHARMACEUTICALS LLC
$60
Alexion Pharmaceuticals, Inc.
$52
RECORDATI_RARE_DISEASES_INC.
$49
PUMA BIOTECHNOLOGY, INC.
$45
TerSera Therapeutics LLC
$42
EMD Serono, Inc.
$34
Mirati Therapeutics, Inc.
$34
Apellis Pharmaceuticals, Inc.
$33
Pharmacosmos Therapeutics Inc.
$31
Immunocore Limited
$30
ADC Therapeutics America, Inc.
$25
Aveo Pharmaceuticals, Inc.
$25
Novocure Inc.
$18
ARRAY BIOPHARMA INC
$18
Blueprint Medicines Corporation
$17
TAIHO ONCOLOGY, INC.
$16
Kite Pharma, Inc.
$16
Top 3 companies account for 26.7% of 2024 payments
All-time payments by company (2018-2024) ›
Novartis Pharmaceuticals Corporation
$2,845
E.R. Squibb & Sons, L.L.C.
$2,813
Janssen Biotech, Inc.
$2,577
AstraZeneca Pharmaceuticals LP
$1,980
Astellas Pharma US Inc
$1,800
Incyte Corporation
$1,609
PFIZER INC.
$1,383
Seagen Inc.
$1,382
Daiichi Sankyo Inc.
$1,233
Karyopharm Therapeutics Inc.
$1,214
Genentech USA, Inc.
$1,182
NOVARTIS PHARMACEUTICALS CORPORATION
$1,168
GlaxoSmithKline, LLC.
$1,115
Lilly USA, LLC
$1,094
Celgene Corporation
$1,062
Pharmacyclics LLC, An AbbVie Company
$929
Amgen Inc.
$923
GENZYME CORPORATION
$897
Pharmacyclics LLC, an AbbVie Company
$659
ABBVIE INC.
$616
Takeda Pharmaceuticals U.S.A., Inc.
$610
Merck Sharp & Dohme Corporation
$533
Eisai Inc.
$522
Gilead Sciences, Inc.
$500
Pharmacosmos Therapeutics Inc.
$469
Bayer HealthCare Pharmaceuticals Inc.
$428
Dova Pharmaceuticals
$427
Merck Sharp & Dohme LLC
$419
Rigel Pharmaceuticals, Inc.
$370
Ipsen Biopharmaceuticals, Inc
$363
SOBI, INC
$332
Bayer Healthcare Pharmaceuticals Inc.
$298
EISAI INC.
$275
Regeneron Healthcare Solutions, Inc.
$256
Adaptive Biotechnologies Corporation
$210
TESARO, Inc.
$202
Stemline Therapeutics Inc.
$201
Jazz Pharmaceuticals Inc.
$191
Taiho Oncology, Inc.
$191
ARRAY BIOPHARMA INC
$187
Epizyme, Inc.,
$183
Teleflex LLC
$160
Acrotech Biopharma LLC
$158
Aurobindo Pharma USA, Inc.
$157
Mylan Institutional Inc.
$157
Foundation Medicine, Inc.
$152
AVEO Pharmaceuticals, Inc.
$149
Kite Pharma, Inc.
$149
Blueprint Medicines Corporation
$148
Puma Biotechnology, Inc.
$148
EMD Serono, Inc.
$143
Genmab U.S., Inc.
$139
SERVIER PHARMACEUTICALS LLC
$135
Secura Bio, Inc.
$134
TerSera Therapeutics LLC
$131
Coherus Biosciences Inc.
$114
PUMA BIOTECHNOLOGY, INC.
$108
BeiGene USA, Inc.
$105
MorphoSys, US Inc.
$103
Alexion Pharmaceuticals, Inc.
$102
Apellis Pharmaceuticals, Inc.
$99
Tempus AI, Inc
$89
Exelixis Inc.
$87
Verastem, Inc.
$86
SANOFI-AVENTIS U.S. LLC
$85
JAZZ PHARMACEUTICALS INC.
$84
AbbVie, Inc.
$83
AbbVie Inc.
$78
ADC Therapeutics America, Inc.
$70
Heron Therapeutics, Inc.
$66
RECORDATI_RARE_DISEASES_INC.
$66
Seattle Genetics, Inc.
$64
Janssen Pharmaceuticals, Inc
$60
Lexicon Pharmaceuticals, Inc.
$59
Boehringer Ingelheim Pharmaceuticals, Inc.
$54
Acceleron Pharma, Inc.
$54
Mirati Therapeutics, Inc.
$53
Acrotech Biopharma Inc.
$47
Organon LLC
$46
Deciphera Pharmaceuticals Inc.
$44
EUSA Pharma (US) LLC
$42
Aveo Pharmaceuticals, Inc.
$42
Sirtex Medical Inc
$39
TAIHO ONCOLOGY, INC.
$32
Clovis Oncology, Inc.
$30
Immunocore Limited
$30
Sun Pharmaceutical Industries Inc.
$28
Array BioPharma Inc.
$28
Emmaus Medical, Inc.
$28
AMAG Pharmaceuticals, Inc.
$28
TG Therapeutics, Inc.
$27
Global Blood Therapeutics, Inc.
$26
Fresenius Kabi USA, LLC
$23
CTI BioPharma Corp.
$18
Sobi, Inc
$18
Novocure Inc.
$18
SUN PHARMACEUTICAL INDUSTRIES INC.
$17
Sumitomo Pharma America, Inc.
$16
Verity Pharmaceuticals Inc.
$16
Helsinn Therapeutics (U.S.), Inc.
$15
West Therapeutics Development, LLC
$14
Spectrum Pharmaceuticals Inc.
$13
Myovant Sciences Inc.
$13
Innate Pharma, Inc
$11
Fortovia Therapeutics, Inc.
$10
Top 3 companies account for 20.5% of all-time payments
Associated products mentioned in payments ›
ADAKVEO · ADCETRIS · AKYNZEO · ALTUVIIIO · ALUNBRIG · AUGTYRO · AYVAKIT · Abraxane · Alecensa · Aliqopa · Avastin · BAVENCIO · BELEODAQ · BLENREP · BOSULIF · BRAFTOVI · BRUKINSA · Bavencio · Beleodaq · Blincyto · Braftovi · CABLIVI · CABOMETYX · CALQUENCE · CARVYKTI · CINVANTI · CYRAMZA · Cabometyx · Columvi · Copiktra · Cresemba · DARZALEX · DOPTELET · Doptelet · ELIQUIS · ELITEK · ELREXFIO · EMPLICITI · ENHERTU · EPKINLY · ERBITUX · ERLEADA · EVENITY · EXKIVITY · Empaveli · Endari · Enhertu · Epkinly · Erleada · FARYDAK · FERAHEME · FOLOTYN · FOTIVDA · FOUNDATIONONE · FOUNDATIONONE CDX · FOUNDATIONONE LIQUID CDX · FRUZAQLA · FULPHILA · Fabhalta · Farydak · Folotyn · Fulphila · GAZYVA · GENOTROPIN · GILOTRIF · HEMADY · Halaven · Herceptin · IBRANCE · ICLUSIG · IMBRUVICA · IMFINZI · INJECTAFER · INLYTA · INQOVI · INREBIC · Imbruvica · JAKAFI · JEVTANA · Jivi · KANJINTI · KEYTRUDA · KIMMTRAK · KISQALI · KRAZATI · Kadcyla · Kyprolis · LIBTAYO · LONSURF · LORBRENA · LUMAKRAS · LUPRON DEPOT · LUTATHERA · LYNPARZA · Lazanda · Lenvima · Lonsurf · Lumoxiti · Lunsumio · MEKINIST · MONJUVI · MONOFERRIC · MVASI · MYLOTARG · Marqibo · Monoferric · NERLYNX · NINLARO · Nerlynx · Neulasta · Nplate · Nubeqa · ONIVYDE · ONTRUZANT · ONUREG · OPDIVO · OPDUALAG · ORGOVYX · OXBRYTA · Ogivri · Onivyde · Optune · Orserdu · PADCEV · PEMAZYRE · PIQRAY · PLUVICTO · PROMACTA · Padcev · Perjeta · Phesgo · Pomalyst · Prolia · QINLOCK · REBLOZYL · RETEVMO · RYBREVANT · Reblozyl · Revlimid · Rezlidhia · Rubraca · SARCLISA · SCEMBLIX · SIR-Spheres Microspheres · SOMATULINE DEPOT · SPRYCEL · SUSTOL · SUTENT · SYLVANT · Somatuline Depot · Stimufend · Stivarga · Sylvant · TAGRISSO · TAZVERIK · TECENTRIQ · TECVAYLI · TUKYSA · TUMOR LYSIS SYNDROME - DISEASE · Tavalisse · Tazverik · Tibsovo · Tivdak · Trelstar · Trodelvy · Turalio · UKONIQ · ULTOMIRIS · UROLIFT · Udenyca · Ultomiris · VELCADE · VENCLEXTA · VERZENIO · VONJO · VPRIV · VYXEOS · Vectibix · Venclexta · Vitrakvi · Vonjo · Voranigo · XALKORI · XARELTO · XGEVA · XPOVIO · XT CDX · XTANDI · Xermelo · Xofigo · Xospata · Xtandi · YONSA · Yescarta · ZEJULA · ZEPZELCA · ZOLADEX · ZYTIGA · Zevalin · Zoladex · clonoSEQ
Should you be concerned? Payments from pharmaceutical and device companies are legal and common — 57% of U.S. physicians receive at least one. They often reflect legitimate consulting, research, or education. What matters is whether a recommended drug or device appears in your doctor's payment records. If so, consider asking your doctor about it. How to interpret this data →
Most payments (89%) are for meals and travel — low-value interactions that are common across virtually all practicing physicians. Total industry engagement is in the top 5% for optician in NJ.
Geographic Context
Opticians within 10 mi
612
Per 100K population
116.8
County median income
$86,384
Nearest hospital
WEST JERSEY HOSPITAL
0.0 mi
0.0 mi
Data Sources
| Provider Registry | ✓ NPPES | Weekly updates |
| Medicare Enrollment | ✓ PECOS | Monthly updates |
| Practice Data | ✓ Medicare Util. | Annual (CY lag) |
| Industry Payments | ✓ Open Payments | CY 2024 |
| Disciplinary History | — Not public | N/A |
This provider has data in 4 of 4 available federal datasets, with a Data Coverage level of Very High. This reflects how much public data is available about a provider. How we calculate this →
Summary
Dr. Gordon is a mixed practice specialist, with above-average Medicare volume (top 0% in NJ), with low-engagement industry engagement in the top 5% of NJ peers, with 21 years of NPI registration.
This summary is auto-generated from federal data, describing data availability and patterns. Read our methodology →
Frequently Asked Questions
Is Dr. Gordon experienced with iron infusion (injectafer)?
Based on Medicare claims data, Dr. Gordon performed 150,000 iron infusion (injectafer) services. Research suggests that higher procedure volume is often associated with better outcomes, particularly for complex procedures. Note that Medicare data only captures patients aged 65 and older, so the total practice volume across all patients is likely higher.
Does Dr. Gordon receive payments from pharmaceutical companies?
Yes. Dr. Gordon received a total of $40,199 from 105 companies across 1,785 individual payments. These payments are legal, publicly disclosed under the federal Sunshine Act, and common among physicians — 57% of all U.S. physicians receive at least one industry payment. Patients may wish to ask their doctor about these relationships, especially if a recommended drug or device appears in the payment records.
How do Dr. Gordon's costs compare to other opticians in Voorhees?
Dr. Gordon's average Medicare payment per service is $2. Note that these figures represent what Medicare pays, not your out-of-pocket cost, which depends on your specific insurance plan and deductible. Procedure-level data above shows both what was submitted and what Medicare paid for each service type.
What does Data Coverage mean?
Data Coverage (currently Very High for Dr. Gordon) measures how much public federal data is available about a provider. It is not a quality rating. A "Very High" or "High" level means the provider has data across multiple federal sources (NPPES, PECOS, Medicare Utilization, Open Payments), indicating a long track record of practice, Medicare participation, and industry disclosure. A "Low" or "Moderate" level may simply mean the provider is newer, does not see Medicare patients, or has not received any industry payments — none of which are inherently negative. Read our full methodology →
Is this data up to date?
Each data source has its own update cycle. Provider registry data (NPPES) is updated weekly. Medicare enrollment (PECOS) is updated monthly. Medicare practice data has a ~2 year lag — the most recent available is typically 2 years prior. Industry payment data (Open Payments) is published annually, usually in June, covering the prior calendar year. We display the data date prominently on each section so you always know how current it is. See our data freshness policy →
Explore related providers
Same specialty & city
Opticians in Voorhees
Browse opticians in Voorhees ranked by procedure volume and transparency data.
Highest volume
Top Opticians in NJ
Opticians ranked by total Medicare services performed statewide.
Industry payments
Pharma Payments to Opticians in NJ
Which NJ opticians receive the most from drug and device companies.
By company
Novartis Pharmaceuticals Corporation Payments to Doctors
See all physicians who received payments from Novartis Pharmaceuticals Corporation.
By company
E.R. Squibb & Sons, L.L.C. Payments to Doctors
See all physicians who received payments from E.R. Squibb & Sons, L.L.C.
By company
Janssen Biotech, Inc. Payments to Doctors
See all physicians who received payments from Janssen Biotech, Inc.
About this page
All data on this page is sourced verbatim from public federal records published by the U.S. Centers for Medicare & Medicaid Services (CMS): NPPES ↗, Open Payments ↗, Medicare Provider Utilization ↗, and PECOS. Publication is mandated by the Physician Payments Sunshine Act (§6002 ACA, 42 U.S.C. §1320a-7h) and the Freedom of Information Act.
This page is not medical advice, an endorsement, a recommendation, or a quality rating. Data Coverage reflects data completeness — how much federal information exists for this provider — not clinical performance, patient outcomes, or quality of care. Always verify information directly with the provider and consult a licensed clinician before making medical decisions.
Provider corrections: Provider portal · Privacy questions: Privacy Policy · Terms: Terms of Use · Methodology: Methodology